Cancer immunotherapy

Results: 490



#Item
191Bevacizumab / Glioma / Glioblastoma multiforme / Melanoma / Clinical trial / Oncology / Immunotherapy / Biomarker / Chemotherapy / Medicine / Brain tumor / Cancer treatments

www.theibta.org We are an alliance of brain tumour support, advocacy and information groups around the world, including brain tumour patients and caregivers, researchers, scientists, clinicians and allied health professi

Add to Reading List

Source URL: theibta.org

Language: English - Date: 2014-10-21 23:18:27
192Lung cancer / Quinazolines / Amides / Aromatic amines / Afatinib / Cancer vaccine / Boehringer Ingelheim / Protein kinase inhibitor / Cancer immunotherapy / Medicine / Chemistry / Cancer treatments

Press Release For US Media Boehringer Ingelheim and CureVac announce collaboration to develop next generation lung cancer immunotherapy 

Add to Reading List

Source URL: www.curevac.com

Language: English - Date: 2014-09-18 07:07:16
193

Pressemitteilung Medigene gibt Publikation zur DC-Impfstoffentwicklung für Phase I/II-Studie in akuter myeloischer Leukämie in “Cancer Immunology, Immunotherapy” bekannt Martinsried/München, 16. Oktober[removed]Die

Add to Reading List

Source URL: hugin.info

Language: German - Date: 2014-10-15 11:23:14
    194Cancer treatments / Cancer research / Skin cancer / Vemurafenib / Immunotherapy / Metastasis / Cancer / Wistar Institute / James A. Schlipmann Melanoma Cancer Foundation / Medicine / Cancer organizations / Melanoma

    2014 SMR Congress Agenda All meetings will take place at the Kongresshaus located at Gotthardstrasse 5, Postfach 2523 CH-8022 Zurich (Entrance to the Kongresshaus is located on Claridenstrasse) Thursday, November 13th 12

    Add to Reading List

    Source URL: www.melanomacongress.com

    Language: English - Date: 2014-11-05 18:06:22
    195Immunotherapy / Immune system / Carcinogenesis / Cancer immunotherapy / Oncoantigen / Medicine / Immunology / Cancer treatments

    PDF Document

    Add to Reading List

    Source URL: www.capconcorp.com

    Language: English - Date: 2014-12-04 10:38:20
    196Oncology / Immunotherapy / Cancer immunology / Tumor antigen / Cancer vaccine / Cancer immunotherapy / Antigen / The Cancer Genome Atlas / Cell-mediated immunity / Medicine / Immunology / Immune system

    Bioinformatics for cancer immunology and immunotherapy Zlatko Trajanoski Biocenter, Division for Bioinformatics Innsbruck Medical University

    Add to Reading List

    Source URL: www.biomax.com

    Language: English - Date: 2014-09-26 10:40:31
    197Immunotherapy / Melanoma / Methadone / Cancer / Renal cell carcinoma / Medicine / Cancer treatments / Interleukin 2

    Proleukin® (aldesleukin) for Kidney Cancer Proleukin is a medication used to treat advanced kidney cancer in adults Dosage: 600,000 International Units/kg[removed]mg/kg) dose Route of administration: Intravenous infusion

    Add to Reading List

    Source URL: dev66.geckodesigns.com

    Language: English - Date: 2014-10-30 16:12:46
    198Anatomy / Immune system / Cancer vaccine / Cancer immunotherapy / Immunotherapy / Tumor antigen / Antigen / Major histocompatibility complex / T cell / Medicine / Immunology / Biology

    Immunotope OCPM Vaccine to be Evaluated in Phase I Ovarian Cancer Immunotherapy Clinical Trial Trial to evaluate safety and immune response to multi-antigen immunotherapeutic vaccine DOYLESTOWN PA (August 19, [removed]Immu

    Add to Reading List

    Source URL: www.immunotope.com

    Language: English - Date: 2005-10-13 09:14:57
    199Immunology / Autoimmune diseases / Immunotherapy / Biologic / Ulcerative colitis / Clinical trial / Medicine / Health / Pharmacology

    Life Sciences BC Breakfast Series An Innovative Immunotherapy Platform for the Treatment of Cancer and Immune-related Diseases October 2, 2014 Hal Gunn M.D. CEO

    Add to Reading List

    Source URL: www.lifesciencesbc.ca

    Language: English - Date: 2014-10-09 18:22:03
    200Cell therapy / Immunology / Lloyd J. Old / Immunotherapy / Biology / T cells / Biotechnology

    PRESS RELEASE – ADAPTIMMUNE LIMITED Adaptimmune secures $104 million in Series A Financing Company will use funding to advance programmes in multiple cancer indications (Oxford, UK and Philadelphia, PA, 25 September 2

    Add to Reading List

    Source URL: www.adaptimmune.com

    Language: English - Date: 2014-09-24 16:53:37
    UPDATE